文献速递临床试验与 GCP真实世界研究与卫生经济

老年侧方压缩1型骨折内固定(L1FE):比较INFIX手术与非手术治疗成人侧方压缩1型脆性骨折效果的一项随机对照试验(含内部预试验)研究方案

Lateral compression type 1 fracture fixation in the elderly (L1FE): study protocol for a randomised controlled trial (with internal pilot) comparing the effects of INFIX surgery and non-surgical management for treating patients with lateral compression type 1 (LC-1) fragility fractures.
PubMed 文献 · Trials · 2023-02-02

L1FE试验是一项多中心随机对照试验,计划纳入600例60岁及以上侧方压缩1型脆性骨折患者,按1:1随机分配至非手术治疗组或INFIX手术组,主要结局为6个月内患者报告的生活质量(EQ-5D-5L)。研究包含12个月内部预试验以评估招募与可行性,旨在比较手术与非手术治疗的临床与成本效果。

要点

  • 老年侧方压缩1型脆性骨折常见且疼痛,可致活动能力下降,当前标准治疗为非手术管理。
  • INFIX是一种经皮放置、无外露针道的骨盆固定装置,在骨质疏松骨中仍有良好把持力,可能耐受性良好。
  • L1FE试验将比较INFIX手术与非手术治疗60岁及以上LC-1脆性骨折的临床与成本效果。

核心结论

  • L1FE研究旨在比较60岁及以上LC-1脆性骨折患者手术与非手术管理的临床与成本效果。
  • 试验据称有足够把握度且设计严谨,可为未来临床与患者决策及NHS资源分配提供信息。

研究设计与样本

  • 多中心随机对照试验,600例患者按1:1分配至非手术治疗组或INFIX手术组。
  • 研究设12个月内部预试验以评估招募与试验可行性。
  • 主要结局为6个月内患者报告的生活质量,采用EQ-5D-5L测量。
  • 次要结局包括身体功能、心理健康、疼痛、谵妄、影像学评估、资源使用和并发症。
  • 试验注册号ISRCTN16478561,注册日期2019年4月8日。

关键数值与推荐

  • 纳入人群为60岁及以上LC-1脆性骨折患者。
  • 主要结局为6个月内EQ-5D-5L测量的患者生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lateral compression type1 (LC-1) fragility fractures are a common, painful injury in older adults resulting in reduced mobility. The incidence of these fractures is increasing with the growing older adult population. The current standard of care is non-surgical management; however, patients with this injury are at risk of long-term immobility and related complications. INFIX is a pelvic fixation device used in younger patients with high-energy fractures. The device is fitted via a percutaneous technique with no external pin sites and has good purchase even in osteoporotic bone. It therefore has the potential to be well tolerated in patients with LC-1 fragility fractures. INFIX could improve patients' ability to mobilise and reduce the risk of immobility-related complications. However, there is a risk of complications related to surgery, and robust evidence is required on patient outcomes. This study will investigate the clinical and cost-effectiveness of surgical fixation with INFIX compared to non-surgical management of LC-1 fragility fractures in older adults. METHODS: A multi-centre randomised controlled trial of 600 patients allocated 1:1 to non-surgical management or INFIX surgery. The study will have a 12-month internal pilot to assess recruitment and trial feasibility. The primary outcome will be the patient quality of life over 6 months, measured by the patient-reported EQ-5D-5L. The secondary outcomes will include physical function, mental health, pain, delirium, imaging assessment, resource use, and complications. DISCUSSION: The L1FE study aims to compare the clinical and cost-effectiveness of surgical and non-surgical management of people aged 60 years and older with LC-1 fragility fractures. The trial is sufficiently powered and rigorously designed to inform future clinical and patient decision-making and allocation of NHS resources. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number Registry ISRCTN16478561. Registered on 8 April 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cook E, Laycock J, Acharya M, et al. Lateral compression type 1 fracture fixation in the elderly (L1FE): study protocol for a randomised controlled trial (with internal pilot) comparing the effects of INFIX surgery and non-surgical management for treating patients with lateral compression type 1 (LC-1) fragility fractures. Trials. 2023. PMID: 36732808. doi:10.1186/s13063-022-07063-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。